Stockreport

FDA OKs Qiagen's ipsogen JAK2 test for all myeloproliferative neoplasms [Seeking Alpha]

Qiagen N.V. Common Shares  (QGEN) 
Last qiagen n.v. common shares earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corporate.qiagen.com/investor-relations
PDF FDA OKs Qiagen's ipsogen JAK2 test for all myeloproliferative neoplasmsThe FDAgrants 510(k) clearance for Qiagen's (NASDAQ:QGEN) ipsogen JAK2 RGQ PCR Kit for additional [Read more]